LGR5 and neoplasm: CRC is the third most commonly diagnosed cancer worldwide in 2022 [26] and in greater than 95% of cases, the Wnt signalling pathway is de-regulated through oncogenic mutations [27] with LGR5 playing a pivotal role in the survival of tumour cells and their metastatic proliferation (extensively reviewed in [19]).